Kala Pharmaceuticals Inc (KALA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $89,480
Last updated: Nov 17, 2026 at 4:10 PM ET
Kala Pharmaceuticals Inc (KALA) Stock Chart
Kala Pharmaceuticals (KALA) has a latest price of $3.43 on Nov 17, 2026. Its price fell 99.7% over the past 12 months. The month-end price fell 100.0% since Jul 2017, a compound annual decline of 74.5%.
Price Chart
From Jul 2017 to Oct 2026, its highest month-end close was $1,899,399.40 in Aug 2017 and its lowest $4.97 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KALA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KALA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 87.3%, and over 6 months it fell 95.5%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 92.2%.
| Period | Change |
|---|---|
| 1 month | -40.6% |
| 3 months | -87.3% |
| 6 months | -95.5% |
| 12 months | -99.7% |
| 12 months, with dividends | -99.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -100.0% | -92.2% |
| 5 years | -100.0% | -86.9% |
| Since Jul 2017 | -100.0% | -74.5% |
Price by Year
Its best calendar year was 2020, when the price rose 83.7%, and its weakest was 2025, when it fell 92.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.97 | -99.4% |
| 2025 | $834.68 | -92.0% |
| 2024 | $10,420.42 | -0.9% |
| 2023 | $10,510.51 | -81.7% |
| 2022 | $57,282.28 | -36.9% |
| 2021 | $90,840.84 | -82.2% |
| 2020 | $509,009.01 | +83.7% |
| 2019 | $277,027.03 | -24.5% |
| 2018 | $367,117.12 | -73.6% |
Trading Range
The price is 63.8% below its 50-day average of $9.49 and 97.7% below its 200-day average of $151.61.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.43 | |
| 50-day average | $9.49 | -63.8% |
| 200-day average | $151.61 | -97.7% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | 2.92 |
| Largest fall, 1 year | -99.8% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KALA
What is KALA's 1-year price change?
Kala Pharmaceuticals's price fell 99.7% over the past 12 months. With dividends included, the 12-month total return was -99.7%.
What is KALA's 5-year price change?
Kala Pharmaceuticals's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 86.9%. These figures leave out dividends.
What is KALA's beta?
Kala Pharmaceuticals's 1-year beta against the S&P 500 is 2.92, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 99.8%.
Is the KALA chart free?
Yes. Advanced Charting for KALA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KALA pages: Overview, Charting, Earnings, Financials, Statistics, Competitors